A New Anticoagulant
Tech ID: 19476 / UC Case 2000-035-0
Technology DescriptionStudies have shown that a compound under investigation causes inhibition of blood clotting in mice. The compound, when administered by intravenous tail injection, destroys circulating coagulation factors and therefore acts as a potent anti-coagulant. The in vivo experiments, in combination with in vitro tests on isolated blood clotting factors, support the theory that the compound causes its effects by proteolysis.